Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. (Q34414177)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. |
scientific article |
Statements
1 reference
Zoledronic acid preserves bone mineral density in premenopausal women who develop ovarian failure due to adjuvant chemotherapy: final results from CALGB trial 79809. (English)
1 reference
E Winer
1 reference
C L Shapiro
1 reference
S Halabi
1 reference
V Hars
1 reference
L Archer
1 reference
D Weckstein
1 reference
J Kirshner
1 reference
W Sikov
1 reference
H J Burstein
1 reference
C Hudis
1 reference
C Isaacs
1 reference
R Schilsky
1 reference
E Paskett
1 reference
14 February 2011
1 reference
1 reference
47
1 reference
5
1 reference
683-689
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference